Department of Physical Therapy, School of Health and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Physical Therapy, Associate Dean for Research, College of Health, University of Utah, Salt Lake City, UT, USA.
Osteoarthritis Cartilage. 2016 Aug;24(8):1340-9. doi: 10.1016/j.joca.2016.03.001. Epub 2016 Mar 10.
OBJECTIVE: (1) Do treatment effects differ between participants receiving manual therapy (MT) with exercise compared to subjects who don't, (2) are treatment effects sustained better when participants receive booster sessions compared to those who don't over a one year period in subjects with knee osteoarthritis (KOA)? DESIGN: Multi-center, 2 × 2 factorial randomized clinical trial. 300 participants with knee OA were randomized to four groups: exercise-no boosters (Ex), exercise-with boosters (Ex+B), manual therapy+exercise-no boosters (MT+Ex), manual therapy+exercise-with boosters (MT+Ex+B). The primary outcome was the Western Ontario and McMaster osteoarthritis index (WOMAC) at 1 year. Secondary outcomes included knee pain, physical performance tests, and proportions of participants meeting treatment responder criteria. RESULTS: There were no differences between groups on the WOMAC at 1 year or on any performance-based measures. Secondary analyses indicated a) better scores on the WOMAC and greater odds of being a treatment responder at 9 weeks for participants receiving MT, b) greater odds of being a treatment responder at 1 year for participants receiving boosters. Exploratory interaction analysis suggested knee pain decreases for participants receiving boosters and increases for participants not receiving boosters from 9 weeks to 1 year. CONCLUSIONS: MT or use of boosters with exercise did not result in additive improvement in the primary outcome at 1 year. Secondary outcomes suggest MT may have some short term benefit, and booster sessions may improve responder status and knee pain at 1 year. However, the role of booster sessions remains unclear in sustaining treatment effects and warrants further study. CLINICAL TRIALS: gov (NCT01314183).
目的:(1)接受手法治疗(MT)加运动的参与者与未接受治疗的参与者相比,治疗效果是否存在差异,(2)在一年的时间内,接受增强治疗的参与者与未接受治疗的参与者相比,治疗效果是否更持久。在膝骨关节炎(KOA)患者中?
设计:多中心、2×2 析因随机临床试验。300 名膝骨关节炎患者被随机分为四组:运动无增强组(Ex)、运动增强组(Ex+B)、手法治疗+运动无增强组(MT+Ex)、手法治疗+运动增强组(MT+Ex+B)。主要结局是 1 年时的西部安大略省和麦克马斯特骨关节炎指数(WOMAC)。次要结局包括膝关节疼痛、身体表现测试和符合治疗反应者标准的参与者比例。
结果:1 年后,各组间 WOMAC 评分或任何基于表现的测量值均无差异。二次分析表明:a)接受 MT 的参与者在 WOMAC 上的得分更好,在 9 周时更有可能成为治疗反应者,b)接受增强治疗的参与者在 1 年时更有可能成为治疗反应者。探索性交互分析表明,从 9 周到 1 年,接受增强治疗的参与者的膝关节疼痛减轻,而未接受增强治疗的参与者的膝关节疼痛增加。
结论:MT 或与运动结合使用增强剂在 1 年内未导致主要结局的额外改善。次要结局表明 MT 可能有一些短期获益,而增强治疗可能在 1 年时改善反应者状态和膝关节疼痛。然而,增强治疗在维持治疗效果方面的作用仍不清楚,需要进一步研究。
临床试验:gov(NCT01314183)。
Arthritis Care Res (Hoboken). 2014-11
Arthritis Care Res (Hoboken). 2025-6
Cochrane Database Syst Rev. 2024-12-3
Osteoarthr Cartil Open. 2024-3-19
Arch Physiother. 2024-2-26
Osteoarthr Cartil Open. 2023-5-10